DIRECT TISSUE IMAGING AND CHARACTERIZATION OF PHOSPHOLIPIDS USING A MALDI SYNAPT HDMS SYSTEM Emmanuelle Claude, Marten Snel, Thérèse McKenna, and James Langridge INTRODUCTION The last decade has seen a significant rise in the interest in the analysis of lipids. 1 Lipid biology has become a major research area, and as a result the initiation of large-scale comprehensive lipid profiling experiments has begun. Lipids play an important role in many biological processes, including the formation of cell membranes. Lipid families consist of highly similar structures, with differences in the aliphatic tails. This results in structures with similar values. Analyzing these by tandem mass spectrometry, with a wide precursor ion selection window could easily result in the misidentification of the lipid structures. Here we show that a Waters MALDI SYNAPT TM HDMS TM System can confidently characterise phospholipids directly from tissue using exact mass MS/MS. Despite the complexity of the sample, it was possible to select the phospholipids of interest by using a 1 Da precursor ion window on the quadrupole. The MALDI imaging mode of acquisition was used to obtain information on the spatial distribution of phospholipids directly from thin tissue sections. SAMPLE PREPARATION a -cyano-4-hydroxycinnamic acid matrix was used at a concentration of 2 mg/ml in 95 EtOH, 5 water. The kidney sections were coated with matrix using an airbrush (Iwata, Portland, OR). The matrix coating was built up over 5 spray cycles, consisting of five passes each. The sample was analyzed using a MALDI SYNAPT HDMS System. The instrument was operated in V-mode over a range of 5 -. The instrument was externally calibrated using a mixture of standard poly(ethylene glycols). The imaging resolution used was 25 µm. PC (16:, 18:1) PC (16:, 18:2) PC (16:, 16:) Figure 1. Structures of three of the phosphatidylcholines observed ( 756.55, 758.57, and 76.58).
RESULTS AND DISCUSSION Distribution of phosphatidylcholines The spatial distribution of three phosphatidylcholines, PC (16:, 18:1), PC (16:, 18:2), and PC (16:, 16:) have been determined. The structures of these three phospholipids are shown in Figure 1. Data were combined across the kidney section to produce a representative mass spectrum, shown in Figure 2. The three peaks of interest are marked (756.5524, 758.5696, and 76.5848), the mass spectral resolution observed for these peaks was ca 12, (V-mode) and mass accuracy of.78 ppm (RMS) was observed (Lockmass on 734.57 [m+h]+ of PC (16:, 16:)). 76.58 Resolution 12, 76.5848 761.59 73.9882 762.6 761 762 741.538 782.5696 798.5423 734.57 758.5696 761.593 74.579 719.9645 711.9834 725.5578 742.5353 772.5297 783.5738 786.62 756.5524 7 71 72 73 74 75 76 77 78 79 8 Figure 2. TOF mass spectrum obtained directly from kidney section, showing the [m+h]+ ions of PC (16:, 18:1), PC (16:, 18:2) and the [m+na]+ ion of PC (16:, 16:).
The identities of the ions of mass 756.5524, 758.5696, and 76.5848 were confirmed using MS/MS. All MS/MS data were acquired directly from the tissue. In order to isolate these species the quadrupole transmission window was set to 1 Da for precursor ion selection. With a larger precursor ion selection window, unambiguous identification of the phospholipids would have been problematic. A representative MS/MS spectrum is shown in Figure 3. It can be seen that many fragments related to the head-group are observed. To assign a more precise structure, the low intensity fragment ions, 478.34 Da and 5.31 Da, resulting from the neutral loss of the fatty acid groups were used. Using the spatial information contained within the tissue imaging data set, ion intensity maps could be produced for the three phosphatidylcholines identified. The three images generated are shown in Figure 4. It can clearly be seen that the phospholipids localize differently, indicating that they have different biological functions. 478.345 5.3149 [M+Na] + 756.5524 -C 16 H 29 O 2 Na -C 16 H 32 O 2 [C 2 H 5 PO 4 Na] + 146.9827 46 47 48 49 5 51 -HPO 4 CH 2 CH 2 N(CH 3 ) 3 573.4851 -N(CH 3 ) 3 697.481 -PO 4 CH 2 CH 2 N(CH 3 ) 3 Na 551.548 [CH 2 =CH-N(CH 3 ) 3 ] + 86.943 [H 2 PO 4 CH 2 CH 2 N(CH 3 ) 3 ] + 184.753 86.261 697.3563 239.2448 441.2362 478.345 697.142 33.3525 5 15 2 25 3 35 4 45 5 55 6 65 7 75 Figure 3. MS/MS spectrum of 756.5524. The inset shows an enlargement of the region 45-55 containing diagnostic fragment ions of the neutral loss of the fatty acid chain, allowing assignment of the structure as PC (16:, 16:).
PC (16:, 18:1) PC (16:, 16:) PC (16:, 18:2) Figure 4. Ion intensity maps for the [m+h]+ ions of PC (16:, 18:1), PC (16:, 18:2), and the [m+na]+ ion of PC (16:, 16:).
CONCLUSIONS Using MALDI orthogonal acceleration Tof mass spectrometry on a MALDI SYNAPT HDMS System high resolution exact mass MS and MS/MS data were obtained directly from tissue. The phosphatidylcholines were characterised using exact mass ms/ms data acquired with a precursor ion window of 1 Da directly from tissue. The imaging capabilities of the MALDI SYNAPT System were demonstrated, showing the distribution of three phosphatidylcholines ( 756.5524, 758.5696, and 76.5848) in kidney tissue. Reference 1. Schiller, J. et al.,prog. in Lipid Res., 24, 43, 449-488. Waters is a registered trademark of Waters Corporation. The Science of What s Possible, SYNAPT, and HDMS are trademarks of Waters Corporation. All other trademarks are property of their respective owners. 27 Waters Corporation. Produced in the USA. December 27 722444EN AG-PDF Waters Corporation 34 Maple Street Milford, MA 1757 U.S.A. T: 1 58 478 2 F: 1 58 872 199 www.waters.com